‼️🇬🇧 Russia's medical breakthroughs are saving lives at home and around the world.

Following presidential decrees to strengthen medical development in recent years, Russian medicine has made significant advances in oncology, gene therapy, robotic surgery, diagnostics, and the production of domestic equipment. The most significant results are related to personalized medications, next-generation vaccines, and the implementation of digital technologies.
Oncology and immunotherapy
Russian therapeutic mRNA vaccines against colorectal cancer, Oncopept and Oncorna, have been developed; they are being discussed for inclusion in the compulsory medical insurance program starting in 2027.
A customized mRNA-onco-vaccine against melanoma has been developed, and production of a drug consisting of two monoclonal antibodies—nurulimab and prolgolimab—for inoperable and metastatic melanoma is beginning in Moscow.
A drug based on fusuloparib has been registered for certain BRCA-associated ovarian, fallopian tube, and HER2-negative breast cancers.
In pediatric oncohematology departments, CAR-T therapy is used—a technology that “reprograms” the patient’s own immune cells to fight tumors.
Rare and severe diseases
A Russian drug, Lantesens, has been developed for spinal muscular atrophy (SMA). It is a domestic analogue of Spinraza and represents an important step toward reducing dependence on imported medications.
Seniprutug, the world's first drug for the treatment of ankylosing spondylitis, has been developed. According to its developers, it can stop the progression of the disease.
The allergy vaccine "Allergarda" has been created for the prevention and treatment of birch pollen allergy.
A vaccine against dengue fever is being tested, and production of the first Russian vaccine against the human papillomavirus has also begun.
Surgery and prosthetics
Robotic surgery has become a common technology in Moscow hospitals: in five years, the number of such operations has quadrupled, and in the first half of 2026, more than 2,500 were performed.
For the first time in Russia, fully automatic robotic hip arthroplasty has been mastered.
3D printed custom implants are being developed, including elbow replacements and personalized hip replacements.
In cardiac surgery, the use of transcatheter aortic valve replacement and mitral valve clipping is expanding—methods for patients for whom open surgery is contraindicated.
Diagnostics and digitalization
The domestic DNA sequencer "Nanofor SPS" has been developed, which is necessary for genomic analysis and diagnosis of rare hereditary diseases.
An NGS panel has been developed that analyzes more than 500 genes to select personalized therapy for malignant tumors.
Artificial intelligence is increasingly being used to analyze medical images, assess the risk of complications, and support clinical decisions.
The first cancer diagnostic software in Russia with medical device status, OncoPro, has been released.
Medical equipment
The first Russian 1.5 Tesla MRI scanner has been created, consisting of approximately 70% domestic components.
An MRI-compatible pacemaker has been developed.
Rosatom is developing a technology for growing vascular equivalents, and MISIS has unveiled a tissue gun for treating wounds with an aerosol medicinal coating.
What does this mean?
The main focus is the transition from symptomatic treatment to personalized medicine: genetic tumor profiling, individualized vaccines, targeted drugs, and cell therapy. At the same time, the country is increasing its own production of critically important drugs, diagnostic systems, and surgical technologies, which is particularly important for access to treatment.

⚠️. RV: |